Search results for "bladder"

showing 10 items of 628 documents

Pharmacotherapy of female urinary incontinence

2005

Urinary incontinence is a major clinical problem and a significant cause of disability and dependency in older adults. Overall, the prevalence of urinary incontinence approaches 55% among women aged over 55 years. The past few years have seen significant advances in the pharmacotherapy of overactive bladder and stress incontinence. The review examines the evidence regarding their benefits and side-effects.

medicine.medical_specialtyStress incontinencebusiness.industryHealth StatusUrinary Incontinence StressAnti-Infective Agents UrinaryUrologyObstetrics and GynecologyEstrogensUrinary incontinenceMuscarinic AntagonistsMiddle Agedmedicine.diseaseAdrenergic AgonistsCholinergic AntagonistsPharmacotherapyOveractive bladderInternal medicineQuality of LifeHumansWomen's HealthMedicineFemalemedicine.symptombusinessBritish Menopause Society Journal
researchProduct

Current Management of Post-radical Prostatectomy Urinary Incontinence

2021

Frontiers in surgery 8, 647656 (2021). doi:10.3389/fsurg.2021.647656 special issue: "Sequelae of Prostate Cancer Therapy: Avoidance strategies and management options / Edited by: clemens M. Rosenbaum, Felix Campos-Juanatey, Luis A. Kluth"

medicine.medical_specialtyStress incontinencemedicine.medical_treatmentlcsh:Surgery030232 urology & nephrologyUrologyUrinary incontinenceReview03 medical and health scienceschemistry.chemical_compoundProstate cancer0302 clinical medicinemedicineDuloxetineprostatectomyProstatectomybusiness.industrylcsh:RD1-811detrusor activityprostate cancerincontinence (male)Neurovascular bundlemedicine.diseasestress incontinenceNeck of urinary bladderchemistry030220 oncology & carcinogenesisSurgeryProstate surgerymedicine.symptombusinessFrontiers in Surgery
researchProduct

Words of Wisdom: Re: A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladd…

2016

medicine.medical_specialtySulfonamidesbusiness.industryUrinary Bladder OveractiveUrologyUrologyProstatic Hyperplasiamedicine.diseaselaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialOveractive bladderlawTamsulosin030220 oncology & carcinogenesisMedicineHumans030212 general & internal medicineProstatic obstructionbusinessMirabegronmedicine.drugEuropean urology
researchProduct

Functional roles of the sweet taste receptor in oral and extraoral tissues

2014

International audience; Purpose of review: This review summarizes and discusses the current knowledge about the physiological roles of the sweet taste receptor in oral and extraoral tissues. Recent findings: The expression of a functional sweet taste receptor has been reported in numerous extragustatory tissues, including the gut, pancreas, bladder, brain and, more recently, bone and adipose tissues. In the gut, this receptor has been suggested to be involved in luminal glucose sensing, the release of some satiety hormones, the expression of glucose transporters, and the maintenance of glucose homeostasis. More recently, the sweet taste receptor was proposed to regulate adipogenesis and bon…

medicine.medical_specialtyTasteinsulinobesitysweetenerProtein ConformationUrinary BladderMedicine (miscellaneous)BiologyBioinformaticsReceptors G-Protein-Coupled03 medical and health sciences0302 clinical medicinestomatognathic systemInternal medicineInsulin Secretion[SDV.IDA]Life Sciences [q-bio]/Food engineeringmedicineAnimalsHumans[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringLymphocytesInsulin secretionReceptor030304 developmental biologyCARBOHYDRATES: Edited by Luc Tappy and Bettina Mittendorfer0303 health sciencesPolymorphism GeneticNutrition and Dieteticsdiabetesdigestive oral and skin physiologyfood and beveragesHeartSweetening agentsSweet tastetaste receptor functionTaste BudsGastrointestinal TractEndocrinologyAdipose TissuecarbohydrateSweetening AgentsTasteModels Animal030217 neurology & neurosurgeryInsulin metabolism
researchProduct

Bladder augmentation using bowel segments (enterocystoplasty)

2012

medicine.medical_specialtyText miningBladder augmentationbusiness.industryUrologyUrologyMedicinebusinessBJU International
researchProduct

Long-term outcome after urinary diversion using the ileocecal segment in children and adolescents: Complications of the efferent segment.

2016

Long-term outcomes are of special concern in children after urinary diversion. In a single institution study we evaluated retrospectively the long-term outcomes of urinary diversion in children, in whom the ileocecal segment had been used, in respect to complications of the efferent segment.The Mainz pouch was used in 107 children for continent urinary diversion. Indications were neurogenic bladder (53%, 57/107), exstrophy-epispadias complex (25%, 27/107), malignancy (13%, 14/107), and others (9%, 9/107). Continent cutaneous diversion was performed in 95 patients, and 12 patients received bladder augmentation/substitution with a continent cutaneous stoma. As efferent segment, we used the in…

medicine.medical_specialtyTime FactorsAdolescentUrologymedicine.medical_treatmentUrinary Bladder030232 urology & nephrologyConstriction PathologicUrinary Diversiondigestive system03 medical and health sciences0302 clinical medicinePostoperative ComplicationsStoma (medicine)IleummedicineHumansChildCecumRetrospective Studiesbusiness.industryUrinary diversionUrinary Bladder DiseasesSurgical Stomasmedicine.diseaseAppendixSurgeryStenosismedicine.anatomical_structureTreatment OutcomeBladder augmentation030220 oncology & carcinogenesisChild PreschoolPediatrics Perinatology and Child HealthPouchComplicationbusinessContinent Urinary DiversionJournal of pediatric urology
researchProduct

Radical Cystectomy - Often Too Late?

1987

From 1967 to 1985, 246 cystectomies for treatment of transitional cell carcinoma of the urinary bladder were performed. Perioperative mortality decreased from 15% in the early years to 0% in 1985. Preoperative radiotherapy was not given. Patients who underwent cystectomy immediately following the diagnosis of invasive bladder carcinoma had a significantly better prognosis than those having cystectomy after recurrence of a transurethrally resected invasive carcinoma in spite of identical G and T criteria. A total of 26 patients who were cystectomized because of tumor recurrence after definitive radiotherapy (salvage cystectomy) represented the group with the worst prognosis: they had a 5-yea…

medicine.medical_specialtyTime FactorsUrologymedicine.medical_treatmentUrologyCystectomyMethodsCarcinomamedicineAdjuvant therapyHumansSurvival rateCarcinoma Transitional CellUrinary bladderBladder cancerbusiness.industryPerioperativeMiddle AgedPrognosismedicine.diseaseSurgerymedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsNeoplasm Recurrence LocalbusinessEuropean Urology
researchProduct

Localization of the bradykinin B2 receptor in uterus, bladder and Madin-Darby canine kidney cells

1997

Kinins are biologically active peptides that act through specific receptors, B1 and B2. Here we describe the localization of the bradykinin B2 receptor in Madin-Darby canine kidney cells and in the uterus and urinary bladder of rat or human origin. We discuss the suitability of anti-peptide antibodies to assess the tissue distribution of bradykinin B2 receptors.

medicine.medical_specialtyTissue FixationReceptor Bradykinin B2Urinary BladderUterusBradykininKidneyRadioligand Assaychemistry.chemical_compoundDogsAntibody SpecificityInternal medicineTumor Cells CulturedmedicineAnimalsHumansTissue DistributionReceptorPharmacologyKidneyParaffin EmbeddingUrinary bladderbiologyurogenital systemReceptors BradykininUterusImmunohistochemistryRadioligand AssayRatsmedicine.anatomical_structureEndocrinologyMicroscopy Fluorescencechemistrybiology.proteinCancer researchAutoradiographyImmunohistochemistryElectrophoresis Polyacrylamide GelFemaleAntibodyCell DivisionImmunopharmacology
researchProduct

Where will the next generation of medical treatments for overactive bladder syndrome come from?

2020

This review article discusses the medical need for improved medical treatments of overactive bladder syndrome, and the hurdles and research required to address that need. Currently, few overactive bladder syndrome patients stay on long-term treatment, largely because efficacy expectations are not met, and tolerability is considered insufficient for the chronic treatment of a non-life-threatening condition. Therefore, a medical need exists for improved tolerability and, even more importantly, improved efficacy. It is unlikely that major improvements of efficacy and tolerability can be achieved within the currently approved drug classes. Work in experimental animals suggests that many causes …

medicine.medical_specialtyUrinary Bladder Overactivebusiness.industryUrology030232 urology & nephrology610 MedizinEfficacy expectationsOveractive bladder syndromeApproved drugReview article03 medical and health sciences0302 clinical medicineTolerabilityDrug development030220 oncology & carcinogenesis610 Medical sciencesmedicineAnimalsHumansBiomarker (medicine)Treatments for overactive bladderIntensive care medicinebusiness
researchProduct

Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis

2001

Objective  To determine the need to standardize the number and location of lymph nodes to be removed during radical cystectomy in patients with invasive bladder carcinoma. Patients and methods  The pelvic lymph nodes from 447 patients (mean age 62.8 years) who underwent radical cystectomy between 1986 and 1997 were evaluated. The number of lymph nodes was correlated with the depth of invasion of the primary tumour (pT), occurrence of nodal metastases, clinical outcome, the operating surgeons and the pathologists dissecting the nodes. Results  The clinical follow-up was available for 302 patients (mean follow-up 38.7 months). The mean (range) number of lymph nodes removed was 14.7 (1–46). Th…

medicine.medical_specialtyUrinary bladderBladder cancerbusiness.industryUrologymedicine.medical_treatmentmedicine.diseaseSurgeryCystectomyTransitional cell carcinomamedicine.anatomical_structuremedicineCarcinomaLymphadenectomyLymphRadiologybusinessLymph nodeBJU International
researchProduct